Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
02/15/2007 | CA2618112A1 Pyridone compound |
02/15/2007 | CA2618103A1 Substituted triazole derivatives as oxytocin antagonists |
02/15/2007 | CA2617557A1 Benzimidazole derivatives as sirtuin modulators |
02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
02/15/2007 | CA2616977A1 Oxazolidinone-quinolone hybrids as antibacterial compounds |
02/15/2007 | CA2616428A1 Pyrazine derivatives useful as adenosine receptor antagonists |
02/15/2007 | CA2615695A1 Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
02/15/2007 | CA2612984A1 Antidiabetic oxazolidinediones and thiazolidinediones |
02/15/2007 | CA2605481A1 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
02/14/2007 | EP1752452A1 Propane-1,3-dione derivative or its salt |
02/14/2007 | EP1751152A2 Azinyl imidazoazine and azinyl carboxamide |
02/14/2007 | EP1751149A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
02/14/2007 | EP1751143A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
02/14/2007 | EP1751141A1 Novel pyridazinone derivatives as inhibitors of cdk2 |
02/14/2007 | EP1751140A1 Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists |
02/14/2007 | EP1751139A2 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
02/14/2007 | EP1751138A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
02/14/2007 | EP1751137A1 Diastereoselective synthesis process for the preparation of imidazole compounds |
02/14/2007 | EP1751136A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
02/14/2007 | EP1751135A1 Process for producing piperidin-2,6-diones heterocyclically substituted at position 3 |
02/14/2007 | EP1751134A1 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents |
02/14/2007 | EP1751133A2 Compositions useful as inhibitors of rock and other protein kinases |
02/14/2007 | EP1751132A1 2-substituted pyrimidines and their use as pesticides |
02/14/2007 | EP1751131A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
02/14/2007 | EP1751124A2 Raf modulators and methods of use |
02/14/2007 | EP1751118A1 Pyrimidines for use as plk inhibitors |
02/14/2007 | EP1751116A2 Pyrimidine compounds and use thereof |
02/14/2007 | EP1751115A1 Theramutein modulators |
02/14/2007 | EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/14/2007 | EP1751111A1 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
02/14/2007 | EP1751105A1 Piperazine derivatives of alkyl oxindoles |
02/14/2007 | EP1751103A1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/14/2007 | EP1670782B1 Quinazoline derivatives |
02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
02/14/2007 | EP1515963B1 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
02/14/2007 | EP1444220B1 Compounds and method for the treatment of overactive bladder |
02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
02/14/2007 | CN1914225A HCV NS-3 serine protease inhibitors |
02/14/2007 | CN1914224A HCV NS-3 serine protease inhibitors |
02/14/2007 | CN1914206A 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
02/14/2007 | CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
02/14/2007 | CN1914195A Substituted quinoline compounds |
02/14/2007 | CN1914194A Therapeutic agent for vasospasm accompanying bypass operation |
02/14/2007 | CN1914193A Heterocyclic anti-migraine agents |
02/14/2007 | CN1914192A Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
02/14/2007 | CN1914191A Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
02/14/2007 | CN1914182A 喹唑啉衍生物 Quinazoline derivatives |
02/14/2007 | CN1914179A Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
02/14/2007 | CN1914173A Quinolines useful in treating cardiovascular disease |
02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
02/14/2007 | CN1911913A New neuropeptide YY5 receptor antagonists |
02/14/2007 | CN1300116C 1H-indazole compound |
02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
02/13/2007 | US7176326 β-Lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes |
02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
02/13/2007 | US7176319 Process for substituted sulfoxides |
02/13/2007 | US7176317 Anthraquinone, xanthene dyes |
02/13/2007 | US7176316 Amino-piperidine derivatives |
02/13/2007 | US7176315 Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer |
02/13/2007 | US7176314 Inflammation modulators |
02/13/2007 | US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
02/13/2007 | US7176312 Kinase inhibitor scaffolds and methods for their preparation |
02/13/2007 | US7176311 Process for preparing pharmaceutically active compounds |
02/13/2007 | US7176306 Hydroxyalkyl cyclic diamine compound |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
02/13/2007 | US7176227 Amine compounds and use thereof |
02/13/2007 | US7176223 5-(3-Pyridylmethyl)imidazolidine-2,4-dione is subjected to a hydrolysis reaction, wherein the reaction is followed by a decarbamation reaction to obtain (3-pyridyl)alanine |
02/13/2007 | US7176222 Contacting a base with an enantiomerically pure hydroxyl group containing compound, reacting the product with a nitro, fluoro-containing benzene compound, reducing the product to the corresponding amine |
02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
02/13/2007 | US7176208 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
02/13/2007 | US7176206 Antibiotics |
02/13/2007 | US7176205 Bi-pyridinyl derivatives as NK-1 antagonists |
02/13/2007 | US7176204 Substituted carboxylic acid derivatives |
02/13/2007 | US7176202 Such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders, rheumatoid arthritis |
02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
02/13/2007 | US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same |
02/13/2007 | US7175670 And an oxidation base; couplers such as N-(3,5-diaminopyrid-2-yl)pyrrolidine; strong, uniform dyeing results between the end and the root, resistant to external agents, capable of giving varied shades |